Efficacy of Triburter on Respiratory Muscle Function in Patients After CABG in Cardiac Rehabilitation Phase II
Sponsored by Fundación Cardiovascular de Colombia
About this trial
Last updated 3 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Patients after Coronary Artery Bypass Graft Surgery
- Older 18 years
- Patients that can able to carry out spirometry and volumen lung measures
- Nyha <2
- Patients in phase 2 of cardiac rehabilitation.
- Absent clinical deterioration
- Mechanical ventilation <24 hours after surgery
Exclusion Criteria
- High risk
- Pneumothorax
- Currently in a clinical trial
- Active smokers
- Patients with COPD
- Major complications hospital period
- Neurological diseases or orthopedic diseases
- Patients who can not be able to carry out the lung function measures.
- Patients with CPAP or BiPAP
- Unable to provide
- Informed consent
- Unstable angina
- Decompensated congestive heart failure.
- Cognitive disorder.
- Uncontrolled arrhythmias.
- Uncontrolled arterial hypertension